Invention Grant
- Patent Title: MGlu 2/3 agonists
- Patent Title (中): MGlu 2/3激动剂
-
Application No.: US13752432Application Date: 2013-01-29
-
Publication No.: US08575214B2Publication Date: 2013-11-05
- Inventor: Stephen Richard Baker , Christopher David Beadle , Barry Peter Clark , James Allen Monn , Lourdes Prieto
- Applicant: Eli Lilly and Company
- Applicant Address: US MN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US MN Indianapolis
- Agent R. Craig Tucker; Danica Hostettler
- Priority: EP12382038 20120201
- Main IPC: A61K31/235
- IPC: A61K31/235 ; A61K31/44
Abstract:
The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.
Public/Granted literature
- US20130197079A1 MGLU 2/3 AGONISTS Public/Granted day:2013-08-01
Information query
